Filing Flows › Comparisons › ARVN vs MNOV
Arvinas vs Medicinova: ARVN and MNOV compared
Arvinas is the larger company: $500K of revenue in its latest quarter (Q3 2026) against $458K for Medicinova (Q2 2026). Medicinova is growing faster (+241% against -99% a year earlier).
Where the money goes: ARVN and MNOV
Arvinas (ARVN) · Q3 2026
Arvinas, Q3 2026: revenue $500K (-99% year over year), net loss $53.9M, operating cash flow −$10.4M. The chart follows the revenue to costs, profit and cash.
Medicinova (MNOV) · Q2 2026
Medicinova, Q2 2026: revenue $458K (+241% year over year), operating margin -554.3%, net loss $2.3M, operating cash flow −$1.9M. The chart follows the revenue to costs, profit and cash.
| Arvinas (ARVN) | Medicinova (MNOV) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q2 2026 |
| Revenue | $500K | $458K |
| Revenue growth, Y/Y | -99% | +241% |
| Operating margin | n/m | -554.3% |
| Net earnings | −$53.9M | −$2.3M |
| Net margin | — | -504.8% |
| Operating cash flow | −$10.4M | −$1.9M |
Questions
Which is bigger, Arvinas or Medicinova?
Arvinas is the larger company: $500K of revenue in its latest quarter (Q3 2026) against $458K for Medicinova (Q2 2026).
Is Arvinas or Medicinova growing faster?
Medicinova is growing faster (+241% against -99% a year earlier).
More: Arvinas earnings · how Arvinas makes money · Medicinova earnings · how Medicinova makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 3, 2026; 10-Q filed Aug 13, 2026). Fiscal quarters can end on different dates. Not investment advice.